1. Home
  2. CRDF vs CPSS Comparison

CRDF vs CPSS Comparison

Compare CRDF & CPSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRDF
  • CPSS
  • Stock Information
  • Founded
  • CRDF 1999
  • CPSS 1991
  • Country
  • CRDF United States
  • CPSS United States
  • Employees
  • CRDF N/A
  • CPSS N/A
  • Industry
  • CRDF Biotechnology: Biological Products (No Diagnostic Substances)
  • CPSS Finance: Consumer Services
  • Sector
  • CRDF Health Care
  • CPSS Finance
  • Exchange
  • CRDF Nasdaq
  • CPSS Nasdaq
  • Market Cap
  • CRDF 288.7M
  • CPSS 225.2M
  • IPO Year
  • CRDF N/A
  • CPSS 1992
  • Fundamental
  • Price
  • CRDF $4.19
  • CPSS $9.18
  • Analyst Decision
  • CRDF Strong Buy
  • CPSS
  • Analyst Count
  • CRDF 4
  • CPSS 0
  • Target Price
  • CRDF $12.00
  • CPSS N/A
  • AVG Volume (30 Days)
  • CRDF 1.1M
  • CPSS 16.4K
  • Earning Date
  • CRDF 05-01-2025
  • CPSS 05-09-2025
  • Dividend Yield
  • CRDF N/A
  • CPSS N/A
  • EPS Growth
  • CRDF N/A
  • CPSS N/A
  • EPS
  • CRDF N/A
  • CPSS 0.79
  • Revenue
  • CRDF $683,000.00
  • CPSS $186,556,000.00
  • Revenue This Year
  • CRDF N/A
  • CPSS N/A
  • Revenue Next Year
  • CRDF N/A
  • CPSS $15.69
  • P/E Ratio
  • CRDF N/A
  • CPSS $11.65
  • Revenue Growth
  • CRDF 39.96
  • CPSS N/A
  • 52 Week Low
  • CRDF $2.01
  • CPSS $7.03
  • 52 Week High
  • CRDF $6.42
  • CPSS $12.73
  • Technical
  • Relative Strength Index (RSI)
  • CRDF 48.00
  • CPSS 34.44
  • Support Level
  • CRDF $3.52
  • CPSS $8.37
  • Resistance Level
  • CRDF $4.31
  • CPSS $9.67
  • Average True Range (ATR)
  • CRDF 0.36
  • CPSS 0.55
  • MACD
  • CRDF -0.07
  • CPSS -0.08
  • Stochastic Oscillator
  • CRDF 28.57
  • CPSS 32.79

About CRDF Cardiff Oncology Inc.

Cardiff Oncology Inc a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies across a range of cancers with the greatest unmet medical need. It is focusing on clinical program in indications such as RAS-mutated metastatic colorectal cancer ("mCRC"), as well as in investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma ("mPDAC"), small cell lung cancer ("SCLC"), and triple negative breast cancer ("TNBC").

About CPSS Consumer Portfolio Services Inc.

Consumer Portfolio Services Inc is a U.S.-based company operating in the specialty finance sector. Its business is to purchase and service retail automobile contracts originated by franchised automobile dealers and, to a lesser extent, by select independent dealers in the United States in the sale of new and used automobiles, light trucks, and passenger vans. Through its automobile contract purchases, the company provides indirect financing to the customers of dealers having limited credit histories, low incomes, or past credit problems, who it refers to as sub-prime customers. It serves as an alternative source of financing for dealers, facilitating sales to customers.

Share on Social Networks: